The aim of this study is to estimate the immediate and lasting effects of the 2014–2015 Ebola virus disease (EVD) outbreak on public-sector primary healthcare delivery in Liberia using 7 years of comprehensive routine health information system data.
Volunteers at the Ebola/Mudslide victims' cemetery at Pa Loko village in the outskirts of Waterloo, Western Area Rural District, have expressed fear that rampant illegal sand mining currently takin
In the recent 2014–2016 Ebola epidemic in West Africa, non-hospitalized cases were an important component of the chain of transmission. However, non-hospitalized cases are at increased risk of going unreported because of barriers to access to healthcare.
The National Institute for Pharmaceutical Research and Development, NIPRD, has successfully researched and developed six traditional herbal products for the treatment of Ebola, malaria and other di
Monrovia — Liberians were dying in their thousands from the Ebola epidemic that plagued the country in 2014 while donor funds sent to the Liberia National Red Cross Society to fight the deadly viru
As if the Ebola crisis in West Africa wasn’t tragic enough, investigators at the International Federation of Red Cross and Red Crescent Societies (IFRC) now say at least USD$6 million was lost to f
West Africa is most at risk of fatal hemorrhagic fever epidemics, including Ebola, researchers said Wednesday, calling for greater preparedness to save lives.
Results from PREVAIL I—a large Ebola vaccine study that enrolled more than a thousand Liberians at Redemption Hospital in Monrovia during the first few months of 2015— have been published in the Oc
The rVSVΔG-ZEBOV-GP vaccine prevented Ebola virus disease when used at 2 × 107 plaque-forming units (PFU) in a trial in Guinea. This study provides further safety and immunogenicity data.
